Recurrent Indolent B-Cell Non-Hodgkin Lymphoma

1

Review clinical trials related to Recurrent Indolent B-Cell Non-Hodgkin Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Standard of care radiation treatment for indolent non-Hodgkin lymphoma is usually delivered in 12 treatments. Studies have shown indolent lymphoma to be sensitive to radiation treatment, however, larger doses have higher rates of toxicities. A reduced radiation dose may be safe, tolerable and/or effective compared to standard of care radiation dose in treating patients with indolent non-Hodgkin lymphoma.

Participants needed: 112
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: Apr 22, 2026Locations: 7
Eligibility criteria

Age ≥ 18 years [+11]

Pregnant women [+5]